MedTrace Logo

Impact of Nutrition Intervention on HIV/AIDS Infected Patients

NCT01171495 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2010-07-28

No results posted yet for this study

Summary

Intervention to investigate the efficacy of a nutritional supplement among ARV-naïve, asymptomatic HIV positive patients with a CD4 count in the range 300-550 cells/ul.

Conditions

  • Human Immunodeficiency Virus (HIV)
  • Acquired Immune Deficiency Syndrome (AIDS)

Interventions

DIETARY_SUPPLEMENT

Theragran-M; Ensure Plus

Theragran-M: One tablet daily for 6-months. Ensure Plus: One 8 fl.oz. bottle daily for 6-months. Nutritional counselling: at baseline, and at monthly follow-up visits.

DIETARY_SUPPLEMENT

Theragran-M

Theragran-M: One tablet daily for 6-months. Nutritional counselling: at baseline and at monthly follow-up visits.

Sponsors & Collaborators

  • The University of The West Indies

    collaborator OTHER

  • Caribbean Health Research Council

    lead OTHER

Principal Investigators

  • Sharon M Dawson, MSc · University of the West Indies, Mona ,Jamaica, West Indies

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • Jamaica

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01171495 on ClinicalTrials.gov